DL-homocysteine
DL-homocysteine is the racemic form of homocysteine, a sulfur-containing amino acid that occupies a central position in one-carbon metabolism and the methionine cycle.
DL-homocysteine is the racemic form of homocysteine, a sulfur-containing amino acid that occupies a central position in one-carbon metabolism and the methionine cycle. In biomedical research, homocysteine is widely treated as a clinically relevant metabolite because its circulating concentration can reflect disruptions in folate and vitamin B12-dependent pathways, altered methylation capacity, and broader metabolic stress. Elevated homocysteine has been associated in recent studies with cognitive decline, neuronal injury, endocrine-metabolic dysregulation, and other disease states.
Although DL-homocysteine itself is a chemical entity rather than a drug, it is frequently studied as a biomarker and mechanistic target in relation to diseases such as Alzheimer's disease, autism spectrum disorder with TORCH-related central nervous system injury, hepatocellular carcinoma, and vitamin B12 deficiency states. Its biological significance lies in its integration with methionine, folate, and DNA methylation biology, as well as its use as a measurable indicator of metabolic imbalance.
Where the papers sit
10 papers from the last 6 months study DL-homocysteine directly · updated from PubMed 10 Nov 2026
Study type 1 clinical trial · 8 observational · 1 human data
Themes 3 themes
-
Homocysteine Prognostic Biomarkers
Elevated homocysteine, alongside methionine, cysteine, lipids and disease markers, is being tested for risk stratification across neurologic, renal and obstetric disease. Studies use logistic regression, ROC curves and AUCs to predict Parkinson's disease, IgA nephropathy, hypertensive-pregnancy neonatal outcomes, intracerebral hemorrhage prognosis and Alzheimer cognitive decline. Panels including PGAM5 and oligomeric α-synuclein extend beyond homocysteine alone. The work supports prognostic association rather than a shared treatment strategy, making external validation central.
5 papers · 50%
-
Homocysteine and Oxidative Stress
Homocysteine is being treated as a biochemical marker linking oxidative stress to diverse neurological and cardiovascular phenotypes. In treatment-resistant depression, electroconvulsive therapy is assessed through changes in glutathione and homocysteine, while pediatric work relates levels to P-wave dispersion. TORCH encephalopathy and autism studies broaden the search for blood predictors. The evidence remains associative, with no consistent therapeutic or mechanistic direction.
3 papers · 30%
-
Cardiometabolic Homocysteine Risk
Homocysteine is being positioned within long-term cardiovascular and kidney risk, especially in advanced Cardiovascular-Kidney-Metabolic syndrome. The main endpoint is mortality, modeled with hazard ratios and Cox regression, rather than a direct homocysteine-lowering outcome. Folic acid combined with resistance training instead examines whether lifestyle and nutritional intervention can alter body composition and blood biomarkers. Together, the studies connect homocysteine with cardiometabolic risk but do not establish that lowering it improves survival.
2 papers · 20%
Papers
The 10 papers from the last 6 months that study DL-homocysteine directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Homocysteine Prognostic Biomarkers (5)
- Plasma-derived hyperhomocysteinemia, PGAM5, and oligomeric α-synuclein as a biomarker panel for idiopathic Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 8 Nov 2026 PMID 43000492
- Predictive value of homocysteine and blood lipid levels in late pregnancy for neonatal outcomes in women with hypertensive disorders of pregnancy. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2 Sept 2026 PMID 42682213
- Homocysteine, cysteine and methionine are associated with 90-day prognosis in intracerebral hemorrhage patients. Annals of medicine · 21 Aug 2026 PMID 42626963
- Association of elevated homocysteine levels with renal pathology and function in patients with IgA nephropathy: a single-center retrospective study. Annals of medicine · 18 Aug 2026 PMID 42610309
- Methionine, Homocysteine, and Methylation Levels Predict Cognitive Decline in Alzheimer's Disease. CNS neuroscience & therapeutics · 27 May 2026 PMID 42201257
Homocysteine and Oxidative Stress (3)
- Changes in Glutathione and Homocysteine Concentrations in Treatment-Resistant Depression After Electroconvulsive Therapy. Medical science monitor : international medical journal of experimental and clinical research · 10 Sept 2026 PMID 42721112
- Association between plasma homocysteine levels and P-wave dispersion in pediatric patients with hyperhomocysteinemia. European journal of pediatrics · 6 Sept 2026 PMID 42701125
- Biochemical Predictors in the Blood Serum of Children with TORCH Encephalopathy and Autism. Journal of molecular neuroscience : MN · 29 May 2026 PMID 42213276
Cardiometabolic Homocysteine Risk (2)
- Association of Homocysteine With All-Cause and Cardiovascular Mortality in Individuals With Advanced Cardiovascular-Kidney-Metabolic Syndrome: A Nationwide Prospective Cohort Study. Medical science monitor : international medical journal of experimental and clinical research · 6 Nov 2026 PMID 42989630
- Effects of folic acid combined with resistance training on body composition and blood biomarkers in adult males. Journal of the International Society of Sports Nutrition · 21 Aug 2026 PMID 42627860
By study type
Clinical trials (1)
- Effects of folic acid combined with resistance training on body composition and blood biomarkers in adult males. Journal of the International Society of Sports Nutrition · 21 Aug 2026 PMID 42627860
Observational studies and case reports (8)
- Plasma-derived hyperhomocysteinemia, PGAM5, and oligomeric α-synuclein as a biomarker panel for idiopathic Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 8 Nov 2026 PMID 43000492
- Association of Homocysteine With All-Cause and Cardiovascular Mortality in Individuals With Advanced Cardiovascular-Kidney-Metabolic Syndrome: A Nationwide Prospective Cohort Study. Medical science monitor : international medical journal of experimental and clinical research · 6 Nov 2026 PMID 42989630
- Changes in Glutathione and Homocysteine Concentrations in Treatment-Resistant Depression After Electroconvulsive Therapy. Medical science monitor : international medical journal of experimental and clinical research · 10 Sept 2026 PMID 42721112
- Association between plasma homocysteine levels and P-wave dispersion in pediatric patients with hyperhomocysteinemia. European journal of pediatrics · 6 Sept 2026 PMID 42701125
- Predictive value of homocysteine and blood lipid levels in late pregnancy for neonatal outcomes in women with hypertensive disorders of pregnancy. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2 Sept 2026 PMID 42682213
- Homocysteine, cysteine and methionine are associated with 90-day prognosis in intracerebral hemorrhage patients. Annals of medicine · 21 Aug 2026 PMID 42626963
- Association of elevated homocysteine levels with renal pathology and function in patients with IgA nephropathy: a single-center retrospective study. Annals of medicine · 18 Aug 2026 PMID 42610309
- Methionine, Homocysteine, and Methylation Levels Predict Cognitive Decline in Alzheimer's Disease. CNS neuroscience & therapeutics · 27 May 2026 PMID 42201257
Human data, design not indexed (1)
- Biochemical Predictors in the Blood Serum of Children with TORCH Encephalopathy and Autism. Journal of molecular neuroscience : MN · 29 May 2026 PMID 42213276
Written from 10 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-09-12 by GPT. Drafted by language models from published abstracts; not medical advice.